SpectraScience, Inc. (OTC: SCIE) is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body, and the Company’s WavSTAT Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis, according to the Company’s website (see here: www.SpectraScience.com). SNNLive caught up with Michael P. Oliver, President and CEO of SpectraScience, Inc. at the LD Micro Invitational 2015 in Bel Air, CA.
Mr. Oliver begins the interview with an overview of the Company. He continues with an update on SpectraScience since the last time we spoke with him in April 2015 (See here: Update with SpectraScience, Inc. on Developments in Europe), as well as a background on how the Company’s technology works.
Mr. Oliver goes on to discuss how the Company is competing with traditional biopsies. Since speaking with Mr. Oliver, the Company has made the following announcements:
For more information about SpectraScience, Inc., go to: www.SpectraScience.com
© 2017 Stock News Now
Supported by Superior Web Solutions